NEXS BIOMEDICA CORPORATION Partners with Microsoft to Transform Biotechnology

ELKRIDGE, Md. - April 2, 2025 - PRLog -- NEXS BIOMEDICA CORPORATION, a leading innovator in biotechnology and pharmaceutical development, today announced a groundbreaking strategic partnership with Microsoft. This collaboration aims to revolutionize drug discovery, development, and delivery through the integration of artificial intelligence, cloud computing, and biotechnological innovations, creating a new paradigm for pharmaceutical research and patient treatment.

"This partnership represents a pivotal moment in biotechnology," said Dr. Marc Nelson, CEO of NEXS BIOMEDICA CORPORATION. "By combining our expertise in biotechnology and pharmaceutical sciences with Microsoft's unparalleled capabilities in cloud infrastructure and AI, we're poised to address some of the most pressing challenges facing drug development today. Together, we'll develop solutions that not only improve therapeutic outcomes but fundamentally transform how medicines are discovered, developed, and delivered."

Partnership Scope

The multi-year partnership will focus on developing integrated pharmaceutical platforms that leverage Microsoft Azure's cloud infrastructure and AI capabilities alongside NEXS BIOMEDICA's proprietary biotechnology and drug development technologies. Key initiatives include creating advanced drug discovery tools, enhancing clinical trial processes, and developing predictive analytics solutions for therapeutic optimization and personalized medicine.

The collaboration will accelerate the development of NEXS BIOMEDICA's next-generation pharmaceutical compounds by integrating research workflows with Microsoft's secure cloud environment, enabling seamless data sharing between researchers while maintaining the highest standards of intellectual property protection and data security.

The partnership will bring breakthrough pharmaceutical and biotechnology solutions to market faster, combining NEXS BIOMEDICA's therapeutic expertise with Microsoft's technological infrastructure to address critical health challenges across the globe.

Patient and Healthcare Benefits

Pharmaceutical researchers will gain access to powerful new tools that enhance drug discovery accuracy, streamline development workflows, and reduce time-to-market. Patients will benefit from more targeted therapeutics, improved treatment outcomes, and enhanced access to innovative medicines through optimized manufacturing and distribution processes.

Accelerated Drug Discovery

AI-powered research tools will help scientists identify promising therapeutic compounds faster and with greater precision

Enhanced Data Security

Microsoft's robust security framework will protect sensitive intellectual property while enabling secure research collaboration

Improved Development Efficiency

Cloud-based solutions will optimize resource allocation and reduce development costs throughout the pharmaceutical pipeline

About NEXS BIOMEDICA CORPORATION

NEXS BIOMEDICA CORPORATION is at the forefront of developing advanced biotechnology and pharmaceutical compounds that bridge the gap between traditional therapeutic approaches and cutting-edge innovations. With a focus on improving patient outcomes through precision medicine and novel drug development, NEXS BIOMEDICA serves healthcare providers worldwide with pharmaceutical solutions that enhance treatment efficacy and patient care.
Learn more at https://www.nexsbiomedica.com

About Microsoft

Microsoft (Nasdaq "MSFT" @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

Media Contact:

Jennifer Wu
Director of Communications
NEXS BIOMEDICA CORPORATION
j.wu@nexsbiomedica.com
571-580-2911